Adenovirus-mediated gene transfer to treat neurologic disease

Archives of Neurology

Volumn 55, Issue 8, 1998, Pages 1061-1064

  Smith, George M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LIPOSOME; RNA;

ADENOVIRUS; BIOLISTIC TRANSFORMATION; CONFERENCE PAPER; DEFECTIVE VIRUS; ENCAPSULATION; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; LIPID BILAYER; MAMMAL CELL; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; SHUTTLE VECTOR; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; NERVOUS SYSTEM DISEASES;

EID: 0031817482     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.8.1061     Document Type: Conference Paper

References (10)

1. Graham FL, Prevec L. Manipulation of adenovirus vectors. In: Murray EJ, ed. Methods in Molecule Biology: Gene Transfer and Expression Protocols. Totowa, NJ: Humana Press; 1991:109-127.
2. Zhang W, Fang X, Branch CD, Mazur W, French BA, Roth JA. Generation and identification of recombinant adenovirus by liposomal-mediated transfection and PCR analysis. Biotechniques. 1993;15:868-874.
3. Eck SL, Alavi JB, Alavi A, et al. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial. Hum Gene Ther. 1996;7:1465-1482.
4. Colak A, Goodman JC, Chen SH, Woo SLC, Grossman RG, Shine HD. Adenovirus-mediated gene therapy for experimental spinal cord tumors: tumoricidal efficacy and functional outcome. Brain Res. 1995;691:76-82.
5. Heise C, Sampson-Johannes A, Williams A, McCormick F, von Hoff DD, Kirn DH. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat Med. 1997;3:639-645.
6. Bilang-Bleuel A, Revah F, Colin P, et al. Intrastriatal injection of adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc Natl Acad Sci U S A. 1997;94:8818-8823.
7. Haase G, Kennel P, Pettmann B, et al. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nat Med. 1997; 3:429-436.
8. 3 receptor. J Neurophysiol. 1997;77:3115-3119.
9. Davidson BL, Bohn MC. Recombinant adenovirus: a gene tansfer vector for study and treatment of CNS disease. Exp Neurol. 1997;144:125-130.
10. Geddes JB, Harding TC, Lightman SL, Uney JB. Long-term gene therapy in the CNS: reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin. Nat Med. 1997;3:1402-1404.